Mean systolic reduction in diagnosed-hypertensive patients
- Crosses the ≥5 mmHg clinical-significance threshold (−4.0 mmHg across all monitored patients)
- 62.2% of patients improved; 42.8% achieved a ≥5 mmHg reduction
- In-target share (<130 systolic) rose from 42.4% to 53.9%; 36.0% of out-of-range starters normalized
Directly supports Controlling High Blood Pressure quality measures and earlier intervention between visits.







